Medical Director- Immuno-Oncology Clinical Development-ICOS

Your Responsibilities:
The Medical Director will be an integral part of the Clinical Team within the GSK Immuno-Oncology (IO) Research Unit (RU). The IO-RU focuses on the pre-clinical, early, and late clinical development of novel, preferentially first-in-class transformational drug-candidates that affect the immune system to maximize tumor control and result in increased survival of patients. Assets includes ICOS agonist, OX40 agonist, TLR-4 agonist and other IO agents.
The Medical Director will be responsible for all aspects related to the clinical development of his/her study.
In this role, the Medical Director will report to the Project Physician Leader (PPL) and belong to multi-functional drug development team(s) and will work closely with scientists, statisticians, and other physicians in the discovery- and translational-medicine groups.
The Medical Director will be reporting within clinical development team(s) consisting of physicians, and clinical scientists. The candidate will provide critical clinical guidance from the selection of a drug candidate to the study that he/she are on. The studies will range from initial proof-of-concept in clinical trial(s) passing through phase I, II, and pivotal phase IIII including regulatory filing and registration. The Medical Director will contribute scientific and medical expertise as well as experience in clinical trial design insights to the activities of the Clinical Team.
• Strategic leadership for clinical development plans
• Management of critical resources and clinical project timelines
• Preparation, design, and/or review of clinical documents, e.g. protocols, investigator's brochures, electronic case report form (e-CRF) design
• Immun-oncology Clinical trial design and optimization
• Data optimization and eCRF creation, optimization, and finalization.
• Participation in interpretation of data analyses of clinical trial results and developing clinical trial reports
• Lead preparation of clinical sections of relevant regulatory filings (IND, study reports, NDA, etc.)
• Serve as the Medical Monitor for clinical trials, to address patient eligibility and treatment questions in cooperation with the contract research organization (CRO) or directly with study investigators
• Participation in site/investigator identification and evaluation for clinical trials; conduct site initiation and engagement calls and visits
• Review safety data for routine medical data review, trend review, and safety signals from ongoing trials
• Review adverse event (AE)/ serious adverse event (SAE) reports from ongoing clinical studies and work in close collaboration with GSK safety /the CRO safety team to review causality and develop MedWatch/CIOMS reports (including narratives and analyses of similar events) for reportable SAEs
• Serve as program medical expert for internal and external collaborators, investigators, consultants, and contract resources
• Represent GSK-Oncology at scientific meetings and presentations
• Contribute to scientific affairs by authoring and / or reviewing abstracts, presentations and manuscripts for medical accuracy and content
• Attend and provide medical support for investigator and consultant meetings (e.g., investigator meetings, clinical advisory boards)
• Develop and manage relationships with key opinion leaders for clinical programs
• Report study conducts, and safety events to PPL

Please use the cover letter to highlight how you meet the qualifications and competencies for the role. Your CV along with your cover letter will be used to assess your application.

Why You?

Basic qualifications:
• M.D. or M.D./Ph.D.
• Board certification/eligibility, and clinical experience in oncology or hematology/oncology preferred
• At least 3 years pharmaceutical or relevant scientific/medical/clinical experience
• Experience or interest in experimental cancer-therapeutics especially immune-oncology is an advantageous
• Early clinical trial (Phase 1 and 2) or late (phase 3) experience in pharmaceutical or biotech industries, or equivalent academic and clinical Oncology experience especially immune-oncology preferred
• Understanding and track record in trial design, conduct, and medical monitoring preferred
• Ability to work proactively and effectively applying creative problem-solving skills
• Excellent strategic planning, organizational and communication skills
• Experience working within or leading high-performance, cross-functional matrix teams

Preferred qualifications:
Board Certified Medical Oncologist or Hematologist/Oncologist

Why GSK?:
GlaxoSmithKline (GSK) is science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK has three world-leading businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer products. Our goal is to be one of the world's most innovative, best performing and trusted healthcare companies.

GSK's powerful combination of skills and resources provides a platform for delivering strong growth and responding quickly to the rapidly changing global healthcare environment. We are focused around three core business: Consumer Healthcare, Pharmaceuticals and Vaccines. With global commercial infrastructure and functional support, international supply networks and innovative R&D, GSK has a global commercial presence in more than 150 markets, a network of 84 manufacturing sites in 36 countries and large R&D centers in the UK, US, Belgium and China. The United States is the single largest market for GlaxoSmithKline.

A more integrated, competitive Pharmaceuticals business is foreseen by significantly strengthening the existing partnership between R&D and commercial. GSK announced its commitment to prioritizing its biggest revenue driver, the pharmaceutical business, recognizing the heart of that business is pharma R&D. Going forward, four key areas will benefit from 80 percent of the R&D budget; respiratory, HIV/infectious diseases, immuno-inflammation and oncology.

Leading GSK in this new era is Emma Walmsley who was appointed CEO in 2017. Several significant leadership appointments including Hal Barron, Chief Scientific Officer and President of R&D, and Luke Miels, President, Global Pharmaceuticals have been made. Both are highly respected leaders with a track record of bringing new medicines to market.

In Oncology, we are focused on delivering transformational therapies that can lengthen the lives of patients with cancer. In 2017, we made significant progress in our emerging portfolio of next generation therapies in the areas of immuno-oncology, cell therapy and epigenetics.

Our 2857916 monoclonal antibody against BCMA has the potential to target a number of tumor types, including relapsed and refractory multiple myeloma. Promising early results suggest a highly competitive profile compared with existing approved treatments for multiple myeloma. It has been granted European PRIME and FDA breakthrough status, potentially resulting in faster review by the regulatory authorities when it is filed.

Contact information:
You may apply for this position online by selecting the Apply now button.
If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK HR Service Centre at 1-877-694-7547 (US Toll Free) or +1 801 567 5155 (outside US).

GSK is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK's compliance to all federal and state US Transparency requirements. For more information, please visit GSK's Transparency Reporting For the Record site.

Back to top